Post
Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities
Merck KGaA has announced two new strategic partnerships with Benevolent AI and Exscientia to support its artificial intelligence (AI)-driven drug …
ADDF invest in BrainScope for Alzheimer’s prediction biomarker
BrainScope has announced an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in an ongoing Series B round to pursue …
ARS hits roadblock for neffy approval as FDA requests additional study
The US Food and Drug Administration (FDA) has asked for repeat-dose study results before granting approval for ARS Pharmaceuticals’s neffy …
Drug manufacturing automation key as populations age, says Lotte Biologics CEO
Widespread adoption of automation in drug manufacturing is key to addressing the healthcare issues that affect ageing populations, said Lotte …
Signal: UK NHS pay row intensifies as doctors launch joint strike
UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …
ARS hits roadblock for neffy approval as FDA requests additional study
The US Food and Drug Administration (FDA) has asked for repeat-dose study results before granting approval for ARS Pharmaceuticals’s neffy …
Drug manufacturing automation key as populations age, says Lotte Biologics CEO
Widespread adoption of automation in drug manufacturing is key to addressing the healthcare issues that affect ageing populations, said Lotte …
Signal: UK NHS pay row intensifies as doctors launch joint strike
UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …
PeptiDream and Genentech enter peptide-RI drug conjugate discovery deal
Japan-based biopharmaceutical company PeptiDream has entered a multi-target partnership and licence agreement with Genentech to discover and develop new macrocyclic peptide-radioisotope (peptide-RI) …
BeiGene agrees with Novartis for global rights to TEVIMBRA
BeiGene has signed an agreement with Novartis to regain global rights related to the humanised IgG4 anti-PD-1 antibody, TEVIMBRA (tislelizumab). Both …
Taysha suspends its lead gene therapy programme after FDA feedback
Taysha Gene Therapies has discontinued its TSHA-120 development for gene therapy following a Type C meeting with the US Food …
FDA grants priority review for Merck’s sNDA of renal cancer therapy
The US Food and Drug Administration (FDA) has accepted supplemental new drug application (sNDA) of Merck’s (MSD) Welireg for advanced renal cell …
Pfizer receives EC approval for LITFULO to treat severe alopecia areata
Pfizer has received marketing authorisation from the European Commission (EC) for LITFULO (ritlecitinib) for the treatment of adults and adolescents …
Kinnate Biopharma announces 70% layoffs and pipeline restructuring
Kinnate Biopharma plans to sack around 70% of its workforce and stop the development of three programmes as a result …
Overcoming disruptions in the pharmaceutical supply chain
On 5 May 2023, the director-general of the World Health Organization declared an official end to Covid-19 as a global …